| 000 | 01300 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250511203022.0 | ||
| 264 | 0 | _c19920129 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0889-7190 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDy, G R | |
| 245 | 0 | 0 |
_aEffect of recombinant human erythropoietin on vascular access. _h[electronic resource] |
| 260 |
_bASAIO transactions _c |
||
| 300 |
_aM274-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aArteriovenous Shunt, Surgical |
| 650 | 0 | 4 | _aBlood Vessel Prosthesis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Occlusion, Vascular _xblood |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolytetrafluoroethylene |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aBloom, E J | |
| 700 | 1 | _aIjelu, G K | |
| 700 | 1 | _aMerritts, G W | |
| 700 | 1 | _aKramer, M S | |
| 700 | 1 | _aRaja, R M | |
| 773 | 0 |
_tASAIO transactions _gvol. 37 _gno. 3 _gp. M274-5 |
|
| 999 |
_c1757540 _d1757540 |
||